In addition, silencing of CUEDC2 expression using an shRNA-mediated method increased the growth of lung adenocarcinoma cells (Fig. 5A), as assessed using the MTT and clone formation assays (Fig. 5B–5D). Here, CUEDC2 is linked to lung adenocarcinoma.